Medical device‐induced thrombosis: what causes it and how can we prevent it? von Jaffer, I. H., Fredenburgh, J. C., Hirsh, J., Weitz, J. I.

Volltext

COMPARISON OF THE EFFECT OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AND WARFARIN ON MECHANICAL HEART VALVE-INDUCED THROMBIN GENERATION von Jaffer, I.H, Stafford, A.R, Fredenburgh, J.C, Whitlock, R.P, Weitz, J.I

Volltext

Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations von Jaffer, I. H., Chan, N., Roberts, R., Fredenburgh, J. C., Eikelboom, J. W., Weitz, J. I.

Volltext

Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential von Wu, C, Stafford, A.R, Fredenburgh, J.C, Weitz, J.I, Gils, Ann, Declerck, Paul, Kim, P.Y

Volltext

A Protease TAMER: a nucleic acid‐based anticoagulant von FREDENBURGH, J. C., KRETZ, C. A., WEITZ, J. I.

Volltext

ANTICOAGULANT PROPERTIES OF HD1, A (PRO)THROMBIN-DIRECTED DNA APTAMER von Kretz, C.A., Stafford, A.R., Fredenburgh, J.C., Weitz, J.I.

Volltext

Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro von FREDENBURGH, J. C, NESHEIM, M. E

Volltext